Search clinical trials for: Active Uveitis

Total 8172 results

University Hospital, Rouen

Not yet recruiting

Efficacy and Tolerance of Baricitinib, a JAK Inhibitor, in the Treatment of Refractory Non-infectious Non-anterior Uveitis (JAKUVEITE)

Active Non-anterior Non-infectious Uveitis
Amgen

Recruiting

Apremilast Pediatric Study in Children With Active Oral Ulcers Associated With Behçet's Disease (BEAN)

Behçet Disease

Spain, United Kingdom, Turkey, France, Greece, Italy, Israel, Switzerland
University Hospital, Bordeaux

Completed

Soluble CD95 Ligand Role in the Pathophysiology of Non-infectious Active Uveitis (UVE-FAS)

Non-Infectious Active Uveitis

France
Eli Lilly and Company

Active, not recruiting

A Study of Baricitinib (LY3009104) in Participants From 2 Years to Less Than 18 Years Old With Active JIA-Associated Uveitis or Chronic Anterior Antinuclear Antibody-Positive Uveitis

Uveitis

France, Spain, Germany, United Kingdom, Italy
Alumis Inc

Active, not recruiting

POC Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Active Intermediate, Posterior, or Pan NIU (OPTYK-1)

Uveitis, Intermediate | Noninfectious Panuveitis | Uveitis Posterior Non-Infectious

United States
Centre Hospitalier Universitaire Dijon

Terminated

A Multicenter Phase 2 Single-arm Proof-of-concept Trial to Assess the Efficacy and Safety of Ustekinumab in Association With Prednisone for the Treatment of Non-infectious Severe Uveitis (NISU) (USTEKINISU)

Patients With Newly Diagnosed Active NISU

France
Santen Inc.

Terminated

LUMINA Phase III Study Assessing the Efficacy and Safety of Intravitreal Injections of 440 ug DE-109 Sirolimus for the Treatment of Active, Non-Infectious Uveitis of the Posterior Segment of the Eye

Non Infectious Uveitis

United States, India, Italy, Argentina
Tarsier Pharma

Completed

A Study to Evaluate TRS01 Eye Drops in Participants With Active Non-infectious Anterior Uveitis

Non-infectious Anterior Uveitis

United States
AbbVie

Active, not recruiting

A Study to Assess Change in Disease Activity and Adverse Events of Adalimumab in Chinese Participants Requiring High Dose Corticosteroids for Active Non-Infectious Intermediate, Posterior, or Pan-Uveitis

Non-infectious Intermediate Posterior- or Pan-uveitis

China
EyePoint Pharmaceuticals, Inc.

Terminated

Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert (FAI)

Uveitis | Uveitis, Posterior | Uveitis, Intermediate

United States
Tarsier Pharma

Completed

A Study of TRS01 in Subjects With Active Non-infectious Anterior Uveitis Including Subjects With Uveitic Glaucoma

Uveitic Glaucoma | Non-infectious Anterior Uveitis

United States, Germany, France
Priovant Therapeutics, Inc.

Active, not recruiting

A Study of Brepocitinib in Adults With Active Non-Infectious Non-Anterior Uveitis (NEPTUNE)

Non-infectious Intermediate Uveitis | Non-infectious Posterior Uveitis | Non-infectious Pan Uveitis

United States
Eyevensys

Completed

A 48 Week Study to Evaluate the Efficacy and Safety of Two (2) EYS606 Treatment Regimens in Subjects With Active Chronic Non-infectious Uveitis (CNIU) (ELECTRO)

Non-infectious Uveitis

United States
Gilead Sciences
Galapagos NV

Terminated

Study to Evaluate the Efficacy and Safety of Filgotinib in Adults With Active Noninfectious Uveitis (HUMBOLDT)

Noninfectious Uveitis

United States, Israel, United Kingdom, Germany, Australia, Canada, New Zealand
Amgen

Completed

A Phase 3 Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Active Behçet's Disease

Behçet's Syndrome

United States, Korea, Republic of, Israel, Italy, Turkey, France, Germany, Greece, Lebanon, Japan
AbbVie

Completed

A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis (VISUAL III)

Uveitis
AbbVie (prior sponsor, Abbott)

Completed

Efficacy and Safety of Adalimumab in Patients With Active Uveitis (VISUAL l)

Uveitis
EyePoint Pharmaceuticals, Inc.

Completed

Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert (FAI)

Non-Infectious Uveitis

United States, United Kingdom, Israel, Hungary, Germany, India
National Eye Institute (NEI)

Completed

Ustekinumab (STELARA) for the Treatment of Active Sight-Threatening Uveitis (STAR Study)

Uveitis

United States
AbbVie

Completed

Impact of Humira® Therapy on Ocular Inflammation, Selected Health Care Resource Utilization and Patient Reported Outcomes in Patients With Active Non-infectious Intermediate, Posterior and Panuveitis in Routine Clinical Practice (HOPE)

Uveitis

Austria, Colombia, Czechia, Germany, Greece, Hungary, Ireland, Israel, Kuwait, Lebanon, Switzerland, United Arab Emirates
Novartis Pharmaceuticals

Completed

Safety,Tolerability and Efficacy of Intravitreal LFG316 in Patients With Active Non-infectious Intermediate-, posterior-or Panuveitis ,

Non-infectious Intermediate Uveitis | Non-infectious Posterior Uveitis | Non-infectious Panuveitis

United States, United Kingdom
Novartis

Withdrawn

Extension Study to Assess Safety and Efficacy of AIN457 in Patients With Active Non-infectious Uveitis (INSURE)

Uveitis

Israel, United States, Switzerland, Canada, Japan
Allergan

Completed

Efficacy and Safety Study of Bimatoprost Sustained-Release (SR) in Participants With Open-angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma, Open-Angle

United States, Hong Kong, Taiwan, Spain, Israel, Australia, Austria, Belgium, Brazil, Denmark, Hungary, Peru, Philippines, Poland
University of Alexandria

Completed

The Role of Rosuvastatin on Vascular Involvement in Behçet's Disease

Behcet's Disease
National Eye Institute (NEI)

Withdrawn

Ustekinumab for Active Sight-Threatening Uveitis

Uveitis
Changhua Christian Hospital

Completed

Long-term Outcome of Punctate Inner Choroidopathy or Multifocal Choroiditis With Active Choroidal Neovascularization Managed With Anti-vascular Endothelial Growth Factor

Choroidal Neovascularization | Punctate Inner Choroidopathy

Taiwan
Washington University School of Medicine
Mallinckrodt

Terminated

Open Label Study of Acthar SQ Gel Injection in Patients With Active Anterior Uveitis

Uveitis

United States
National Eye Institute (NEI)

Completed

Daclizumab to Treat Non-Infectious Sight-Threatening Uveitis

Uveitis

United States
National Eye Institute (NEI)

Completed

Subconjunctival Sirolimus for the Treatment of Autoimmune Active Anterior Uveiti

Anterior Uveitis

United States
National Eye Institute (NEI)

Completed

Differences in Genes and Proteins in Active and Controlled Uveitis

Uveitis | Ocular Inflammatory Disease

United States
University Hospital, Grenoble

Completed

Evaluation of Biological Biomarkers Diagnostic of Toxoplasmosis Uveitis (BIOLUVE)

Subjects Clinically Suspected an Active Source of Toxoplasmosis Chorioretinitis Infection

France
XOMA (US) LLC
Institut de Recherches Internationales Servier

Terminated

Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis (EYEGUARD™-A)

Uveitis

United States, France, Germany, Poland, United Kingdom, China, Spain, Mexico, Portugal, Turkey, Israel, Korea, Republic of, South Africa, Taiwan, Argentina, Brazil, Austria, Russian Federation, Australia, Armenia, Greece, Tunisia
Novartis Pharmaceuticals

Terminated

Safety and Efficacy of AIN457 in Patients With Active Non-infectious Uveitis (INSURE)

Uveitis

Japan, Spain, Egypt, Switzerland, Israel, Germany, Hungary, United States, France, Singapore, United Kingdom, Canada, India
Lux Biosciences, Inc.

Completed

Efficacy and Safety of Voclosporin to Treat Active Noninfectious Uveitis

Noninfectious Uveitis

France, United States, Italy, Germany, Canada, United Kingdom, Czech Republic, Austria, Brazil
Lux Biosciences, Inc.

Completed

A Study of LX211 in Active Sight Threatening, Non-infectious Intermediate-, Anterior and Intermediate-, Posterior-, or Pan-Uveitis (LUMINATE)

Panuveitis | Uveitis, Posterior | Uveitis, Intermediate

United States, United Kingdom, Canada, Germany, Austria, France, India
Lux Biosciences, Inc.

Completed

A Multi-center Study to Assess the Efficacy and Safety of LX211 in Active Non-infectious Anterior Uveitis (LUMINATE)

Uveitis, Anterior | Panuveitis

United Kingdom, Canada, United States, Germany, Austria, France, India
University of Ulster
Northern Health & Social Care Trust (NHSCT); Solvotrin Therapeutics - Active...

Not yet recruiting

Adiposity and Iron Requirements in Pregnancy (ADIPREG)

Iron Deficiency Anemia of Pregnancy

United Kingdom
Dartmouth-Hitchcock Medical Center
Dartmouth College; University of Massachusetts, Worcester

Not yet recruiting

Self-administered ONe-of-a Kind Approach to Epilepsy Therapy Through a Web-based Music Application (SONATA)

Epilepsy | Refractory Epilepsy | Music

United States
University of Valencia

Recruiting

Differences and Changes in Lower Limb Muscle Activation and Ankle Stability in Different Blackboard Configurations

Electromyography

Spain
Universidad Católica San Antonio de Murcia

Not yet recruiting

Upper Limb Blood Flow Restriction in Handball Players

Sports Physical Therapy

Spain
University of Hail

Not yet recruiting

A Randomized Controlled Trial Comparing Controlled Active Motion and Early Passive Mobilization Protocols for Rehabilitation of Repaired Flexor Tendons in Zone II

Flexor Tendon Rupture

Saudi Arabia
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Preoxygenation for Tracheal Aspirations in Intensive Care (POXTRA)

ICU Patients Under Invasive Mechanical Ventilation

France
Koya Medical, Inc.

Recruiting

Clinical Study to Evaluate the Effectiveness and Health Economics of a Novel Portable Non-Pneumatic Active Compression Device (NPCD) for Lymphedema/Phlebolymphedema (GRANDE)

Lymphedema | Chronic Venous Insufficiency | Phlebolymphedema

United States
Hospital Italiano de Buenos Aires

Not yet recruiting

Mortality of MBL-producing Enterobacteriaceae Bacteremias With the Combined Use of Ceftazidime-avibactam and Aztreonam vs. Other Active Antibiotics. A Multicenter Target Trial Emulation.

Bacteremia
VA Office of Research and Development

Not yet recruiting

Ketamine-assisted Integrative Treatment for Veterans With Chronic Low Back Pain and Comorbid Depression

Depression | Chronic Low Back Pain

United States
VA Palo Alto Health Care System
National Institute on Alcohol Abuse and Alcoholism (NIAAA); Stanford University

Not yet recruiting

Developing Functional Connectivity-Guided TMS for Alcohol Use Disorder

Drinking Behavior | Alcoholism | Alcohol Use Disorder | Alcohol Abuse | Drinking Problem

United States
United States Naval Medical Center, San Diego
Minneapolis Veterans Affairs Medical Center; United States Department of Defense and other collaborators

Not yet recruiting

Remotely Supervised tDCS+ for Complex Attention in mTBI (Cognetric)

Brain Injuries | Brain Injuries, Traumatic | Brain Concussion | Mild Cognitive Impairment | Memory Impairment | Mild Traumatic Brain Injury | Attention Impaired | Neurocognitive Dysfunction | Brain Trauma | Attention Concentration Difficulty | Post Concussive Symptoms

United States
Örebro University, Sweden
Region Örebro County

Recruiting

ReActivate: Physiotherapist Led Intervention for Adolescents With Pain and Psychological Distress.

Chronic Pain | Emotional Distress

Sweden
The First Affiliated Hospital with Nanjing Medical...

Not yet recruiting

Research on the Brain Mechanism of taVNS in Regulating PD Motor Symptoms

Parkinson Disease

China
Novo Nordisk A/S

Not yet recruiting

Effects of NNC0194-0499, Cagrilintide, and Semaglutide Alone or in Combinations on Liver Damage and Alcohol Use in People With Alcohol-related Liver Disease

Alcohol-related Liver Disease

Spain, Denmark, United States, Australia, Canada, Netherlands, Italy, Bulgaria, Czechia, Germany, Greece, France, Japan, Poland

Search clinical trials for: Active Uveitis

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Moldova

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations